Curis
CRIS
#10186
Rank
HK$0.10 B
Marketcap
HK$7.44
Share price
-5.93%
Change (1 day)
-66.31%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -HK$0.26 Billion

According to Curis's latest financial reports the company's current earnings are HK$11.65 Million. In 2024 the company made an earning of -HK$0.34 Billion, an increase over its 2023 earnings that were of -HK$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.26 Billion-24.2%
2024 -HK$0.34 Billion-5.77%
2023 -HK$0.36 Billion-13.1%
2022 -HK$0.41 Billion27.52%
2021 -HK$0.33 Billion65.09%
2020 -HK$0.2 Billion-9.1%
2019 -HK$0.22 Billion-4.73%
2018 -HK$0.23 Billion-41.95%
2017 -HK$0.39 Billion-14.37%
2016 -HK$0.46 Billion3.55%
2015 -HK$0.44 Billion271.52%
2014 -HK$0.12 Billion76.64%
2013 -HK$66.38 Million
2011 -HK$56.38 Million27.76%
2010 -HK$44.13 Million-43.87%
2009 -HK$78.62 Million-23.44%
2008 -HK$0.11 Billion56.66%
2007 -HK$65.55 Million-16.71%
2006 -HK$78.7 Million-36.92%
2005 -HK$0.13 Billion156.25%
2004 -HK$48.69 Million-37.24%
2003 -HK$77.58 Million-93.34%
2002 -HK$1.17 Billion86.79%
2001 -HK$0.63 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.75 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.87 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$0.49 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$6.83 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.01 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$0.2 Billion-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.29 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA